董事和高级管理人员所持本公司股份及其变动管理
Search documents
哈药集团人民同泰医药股份有限公司 关于聘任证券事务代表的公告
Zhong Guo Zheng Quan Bao - Zhong Zheng Wang· 2025-11-29 00:03
Group 1 - The company appointed Ms. Qu Rui as the securities affairs representative to assist the board secretary in fulfilling responsibilities, with her term aligned with the current board's term [1][43] - Ms. Qu Rui has no shares in the company and has no related relationships with other directors, senior management, or significant shareholders, meeting the qualifications for the position [1][3] - The company will hold its first extraordinary general meeting of 2025 on December 16, 2025, with both on-site and online voting options available [5][45] Group 2 - The extraordinary general meeting will take place at 14:00 on December 16, 2025, at the company's office in Harbin [6][11] - Shareholders can vote through the Shanghai Stock Exchange's online voting system during specified trading hours on the meeting day [6][8] - The meeting will include voting on previously disclosed proposals, with no special resolutions or related party transactions requiring abstention [7][18]